Deutsche Bank Aktiengesellschaft Increases Aperam (OTCMKTS:APEMY) Price Target to €53.00

Aperam (OTCMKTS:APEMYGet Rating) had its target price increased by stock analysts at Deutsche Bank Aktiengesellschaft from €52.00 ($56.52) to €53.00 ($57.61) in a research report issued on Thursday, The Fly reports. The firm currently has a “buy” rating on the stock.

APEMY has been the subject of several other reports. Morgan Stanley increased their price target on Aperam from €47.00 ($51.09) to €48.00 ($52.17) in a report on Friday, December 9th. JPMorgan Chase & Co. increased their price target on Aperam from €29.50 ($32.07) to €31.40 ($34.13) and gave the stock a “neutral” rating in a report on Wednesday, December 14th. Two equities research analysts have rated the stock with a sell rating, four have assigned a hold rating and two have issued a buy rating to the company. Based on data from, the company presently has a consensus rating of “Hold” and an average target price of $44.87.

Aperam Stock Up 2.8 %

Shares of Aperam stock opened at $38.10 on Thursday. Aperam has a 1 year low of $24.20 and a 1 year high of $61.15. The business has a 50-day moving average of $31.90 and a two-hundred day moving average of $28.90. The company has a market capitalization of $2.97 billion, a P/E ratio of 2.32 and a beta of 1.83. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.85 and a quick ratio of 0.66.

About Aperam

(Get Rating)

Aperam SA, together with its subsidiaries, engages in the production and sale of stainless and specialty steel products worldwide. It operates through three segments: Stainless & Electrical Steel; Services & Solutions; and Alloys & Specialties. The company offers range of stainless steel products, including grain oriented and non-grain oriented electrical steel products, and specialty alloys.

Further Reading

The Fly logo

Analyst Recommendations for Aperam (OTCMKTS:APEMY)

Receive News & Ratings for Aperam Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aperam and related companies with's FREE daily email newsletter.